{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:31:25Z","timestamp":1767713485186,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,2,10]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:p>The clinical course of adenoviral pseudomembranous conjunctivitis is mostly self-limiting and requires only supportive management measures; however, a minority of patients may develop severe inflammation in response to the virus, which can present as subepithelial infiltrates and pseudomembranes. In its most severe form, symblepharon can result from the inflammatory response resulting in longer-term clinical sequelae. The optimal management of adenoviral pseudomembranous conjunctivitis is poorly defined and while debridement is commonly recommended, there is limited evidence base to support this practice. In this paper, we present two cases of PCR-proven adenoviral pseudomembranous conjunctivitis managed conservatively with topical lubricants and corticosteroids rather than debridement to good effect.<\/jats:p>","DOI":"10.1136\/bcr-2022-253014","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:36:31Z","timestamp":1676972191000},"page":"e253014","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Case for conservative management of adenoviral pseudomembranous conjunctivitis"],"prefix":"10.1136","volume":"16","author":[{"given":"Kenneth McNair","family":"Gilmour","sequence":"first","affiliation":[{"name":"Ophthalmology, Tennent Institute of Ophthalmology, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Ramaesh","sequence":"additional","affiliation":[{"name":"Ophthalmology, Tennent Institute of Ophthalmology, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"2025082711160859000_16.2.e253014.1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.optm.2006.11.012","article-title":"The prevalence of adenoviral conjunctivitis at the wills eye hospital emergency room","volume":"78","author":"Sambursky","year":"2007","journal-title":"Optometry"},{"key":"2025082711160859000_16.2.e253014.2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","article-title":"Conjunctivitis: a systematic review","volume":"15","author":"Azari","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"key":"2025082711160859000_16.2.e253014.3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09273948.2010.498658","article-title":"Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis","volume":"18","author":"Chintakuntlawar","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"2025082711160859000_16.2.e253014.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000170693.13326.fb"},{"key":"2025082711160859000_16.2.e253014.5","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1177\/1120672120957581","article-title":"Epidemiology of pseudomembranous conjunctivitis in a tertiary Hospital: a 2-year retrospective study","volume":"31","author":"de-Arriba-Palomero","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"2025082711160859000_16.2.e253014.6","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S162669"},{"key":"2025082711160859000_16.2.e253014.7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s40135-019-00207-y","article-title":"Adenoviral keratoconjunctivitis: diagnosis, management, and prevention","volume":"7","author":"Kuo","year":"2019","journal-title":"Curr Ophthalmol Rep"},{"key":"2025082711160859000_16.2.e253014.8","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0475"},{"key":"2025082711160859000_16.2.e253014.9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/OPTH.S207976","article-title":"Management of adenoviral keratoconjunctivitis: challenges and solutions","volume":"14","author":"Labib","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"2025082711160859000_16.2.e253014.10","unstructured":"Duke-Elder S . Textbook of ophthalmology, volume II. Year 1943:1516\u20137."},{"key":"2025082711160859000_16.2.e253014.11","unstructured":"Duke-Elder S . Inflammations of the conjunctiva and associated inflammations of the cornea. diseases of the outer eye. st. louis: C. V. mosby company. 1965:55\u20136."},{"key":"2025082711160859000_16.2.e253014.12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/ICO.0000000000001982","article-title":"Use of topical steroids in conjunctivitis: a review of the evidence","volume":"38","author":"Holland","year":"2019","journal-title":"Cornea"},{"key":"2025082711160859000_16.2.e253014.13","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0 % and dexamethasone 0.1 % drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"2025082711160859000_16.2.e253014.14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/eye.2017.4","article-title":"Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis","volume":"31","author":"Asena","year":"2017","journal-title":"Eye (Lond)"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-253014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:16:13Z","timestamp":1756318573000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-253014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,21]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/bcr-2022-253014"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-253014","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}